Data / Form D filings / EnPlusOne Biosciences Inc.
EnPlusOne Biosciences Inc.: Form D filings
EnPlusOne Biosciences Inc., a biotechnology company in Watertown, MA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on December 26, 2024, reports $21.8 million sold of a $23.1 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 313 PLEASANT STREET, 4W, Watertown, MA, 02472
- Phone
- (617) 744-6739
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1946593
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | Amendment | $23,146,704 | $21,816,706 | $1,329,998 | 7 | Dec 9, 2024 | sec.gov |
| Dec 26, 2024 | Amendment | $12,896,707 | $12,896,707 | 6 | Apr 10, 2023 | sec.gov | |
| Oct 3, 2022 | New notice | $12,396,705 | $11,896,705 | $500,000 | 6 | Aug 30, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paxton Major | Director | |
| Andrew Lee | Director | |
| Steven Kasok | Director | |
| Daniel Ahlstedt | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 23, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EnPlusOne Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.